CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/18/2022
Back to search
Official data from USPTO
REISTONE BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
07/18/2022
Trademark type
Combined
Nice classes
42
Filing date
05/10/2021
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/03/2018
First use in commerce
12/03/2018
Drawing code
3
Owner type
03
Owner location
Rosemont, IL
Examiner
MOLINOFF, JEFFREY
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of The words "Reistone" and "Biopharma" in a custom designed font, separated by a bold line, with Reistone positioned above the bold line and Biopharma positioned below the bold line.
Holders and representatives
Holders
Reistone Biopharma Inc.
Reistone Biopharma Inc.
Representatives
Jessica R. Manganello NEW LEAF LEGAL, LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biochemical research and development; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines; Research and development of vaccines and medicines; Research in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
15 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/18/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/18/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/01/2022
PUBO
PUBLISHED FOR OPPOSITION
03/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/21/2022
DOCK
ASSIGNED TO EXAMINER
01/13/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2021
NWAP
NEW APPLICATION ENTERED
05/13/2021
Continuous trademark protection
Get notified about every new filing that threatens REISTONE BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.